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Salmonella takes control: effector-driven manipulation of the host
Emma J McGhie, Lyndsey C Brawn, Peter J Hume, Daniel Humphreys and
Vassilis KoronakisSalmonella pathogenesis relies upon the delivery of over thirty
specialised effector proteins into the host cell via two distinct
type III secretion systems. These effectors act in concert to
subvert the host cell cytoskeleton, signal transduction
pathways, membrane trafficking and pro-inflammatory
responses. This allows Salmonella to invade non-phagocytic
epithelial cells, establish and maintain an intracellular
replicative niche and, in some cases, disseminate to cause
systemic disease. This review focuses on the actions of the
effectors on their host cell targets during each stage of
Salmonella infection.
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Introduction
Salmonellae are enteropathogenic Gram-negative bacteria
that infect humans and animals, causing each year 1.3
billion cases of human disease ranging from diarrhoea to
systemic typhoid fever. Following ingestion by the host,
Salmonella invades the intestinal mucosa via several
routes. Bacteria may be taken up by antigen-sampling
M cells, be captured in the lumen by CD18-expressing
phagocytes that penetrate the epithelial monolayer, or
may force their own entry into non-phagocytic entero-
cytes. Upon internalisation into non-phagocytic cells,
Salmonella becomes enclosed within an intracellular pha-
gosomal compartment termed the Salmonella-containing
vacuole (SCV). The maturing SCV traffics towards the
Golgi apparatus, undergoing selective interactions with
the host endocytic pathway. Once positioned within the
perinuclear area, the SCV-enclosed bacteria replicate, a
stage characterised by formation of tubulovesicular SCV
Open access under CC BY license.www.sciencedirect.comstructures called Salmonella-induced filaments (Sifs).
Although most Salmonella infections remain localised to
the intestine, where stimulation of inflammatory
responses contributes to diarrhoea, in typhoid disease
Salmonella survives in intestinal macrophages, dissemi-
nating to the liver and spleen via the bloodstream and
lymphatic system (Figure 1). This multi stage infection of
the host is directed by Salmonella-mediated delivery of an
array of specialised effector proteins into the eukaryotic
host cells via two distinct type III secretion systems
(T3SSs), encoded by pathogenicity islands 1 (SPI-1
T3SS) and 2 (SPI-2 T3SS). Additional secretion systems,
including the sci-encoded (Salmonella enterica centisome 7
genomic island) type VI secretion system [1] and the
ZirTS pathway [2], appear to be functional during Sal-
monella infection and have been demonstrated to con-
tribute towards virulence. However, these systems are not
currently well characterised compared to the SPI-1 and
SPI-2 T3SSs.
Over thirty SPI-1 and SPI-2 T3SS effectors have been
shown to manipulate a succession of key host cellular
functions, including signal transduction, membrane traf-
ficking and pro-inflammatory immune responses
(Tables 1 and 2, see Supplementary information for fully
referenced versions). In this review, we will summarise
the actions of these effectors on their host cell targets and
indicate emerging examples of effector cooperation.
Effector-mediated forced entry into non-
phagocytic epithelial cells
A subset of delivered SPI-1 effectors (SipA, SipC, SopB,
SopD, SopE, SopE2) function to induce membrane
deformation and rearrangement of the underlying actin
cytoskeleton (‘membrane ruffling’), triggering bacterial
internalisation into SCVs.
TheC-terminus of the SPI-1 T3SS translocon component
SipC (SspC) directly nucleates actin assembly leading to
rapid filament growth from barbed ends, whereas its N-
terminus bundles actin filaments [3]. Although not
necessary for Salmonella entry, SipA (SspA) increases
invasion efficiency into cultured cells [3] and enhances
Salmonella enterocolitis in vivo [4]. SipA promotes actin
polymerisation by reducing the critical concentration for
actin assembly [3] and binds to F-actin with high affinity,
resulting in mechanical stabilisation of filaments [3,5,6].
SipA potentiates the actin nucleating and bundling activi-
ties of SipC [3] and enhances the activity of the host
actin bundling protein T-plastin (fimbrin) [3,6]. SipA alsoCurrent Opinion in Microbiology 2009, 12:117–124
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Figure 1
Schematic representation of the major stages underlying Salmonella infection. Salmonellae invade non-phagocytic cells by inducing membrane
deformation and rearrangement of the underlying actin cytoskeleton (membrane ruffling), enclosing bacteria in intracellular phagosomal compartments
termed Salmonella-containing vacuoles (SCVs). SCVs traffic towards the perinuclear region of the host cell and mature via selective interactions with
the endocytic pathway. Once the SCV is positioned next to the Golgi apparatus, intracellular bacterial replication begins. This stage is characterised by
the formation of SCV tubulovesicular structures called Salmonella-induced filaments (Sifs) and the accumulation of F-actin around the bacterial
phagosome (actin nest). Chloride ion (Cl-) secretion and polymorphonuclear leukocyte (PMN) transmigration contribute towards diarrhoea and
intestinal inflammation. In addition, Salmonella manipulates specific host immune response pathways. Salmonella serovars associated with systemic
disease are able to enter intestinal macrophages, inducing cell death as well as using them as a vehicle to disseminate to the liver and spleen via the
bloodstream and lymphatic system. SPI-1 and SPI-2 effectors involved in each individual infection stage are indicated. Note that SPI-1 and SPI-2
effectors do not operate sequentially and independently of one another as previously thought. Instead, both subsets play key roles in SCV maturation,
positioning and replication (Abbreviations: ER, endoplasmic reticulum; TGN, trans-Golgi network).prevents binding of the cellular actin depolymerising
proteins ADF/cofilin to F-actin and displaces pre-bound
ADF/cofilin from F-actin [5]. The F-actin severing
activity of cellular gelsolin was originally reported to be
prevented by SipA [5], but a later study showed that
higher concentrations of gelsolin were able to partially
sever SipA-F-actin complexes [7]. In addition, SipA is
able to reanneal gelsolin-severed and -capped actin fila-
ment fragments [5,7].
In contrast to SipA and SipC, SopE and SopE2 do not
bind actin. They modulate the host actin cytoskeleton
indirectly bymimicking cellular guanine exchange factors
(GEFs) [6]. In particular, they catalyse the exchange of
bound GDP for GTP to activate host Rho GTPases that
stimulate downstream pathways that drive actin cyto-Current Opinion in Microbiology 2009, 12:117–124skeletal assembly via Arp2/3. In vitro, SopE and SopE2
have differing substrate specificities; while SopE acti-
vates Rac-1 and Cdc42, SopE2 appears to exhibit speci-
ficity for Cdc42 [6]. SopE-dependent activation of Rac-1
alone appears sufficient for bacterial internalisation [8].
The inositol phosphatase SopB (SigD) dephosphorylates
a range of phosphoinositide phosphate and inositol phos-
phate substrates in vitro [4,6]. Inhibition of SopB phos-
phoinositide phosphatase activity attenuates Salmonella-
induced cytoskeletal reorganisation [6]. Recent work
indicates that SopB-dependent stimulation of the cellular
SH3-containing guanine nucleotide exchange factor,
SGEF, activates the small GTPase RhoG, which contrib-
utes to the actin remodelling that occurs during Salmo-
nella entry [8].www.sciencedirect.com
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Table 1
Effectors requiring the SPI-1-encoded T3SS for their translocation.
Effector Gene location Selected homologues Activity Host cell target(s) Role in infection
AvrA SPI-1 Yersinia YopJ/P Cysteine protease with
deubiquitinase activity,
acetyltransferase
MKK4/7, IkBa, b-catenin Inhibits inflammation, represses apoptosis &
epithelial innate immunity
SipA (SspA) SPI-1 Shigella IpaA Actin binding/stabilising Actin, T-plastin Increases internalisation efficiency, enhances
actin assembly, potentiates SipC activity,
triggers PMN transmigration, maintains
perinuclear SCV positioning, disrupts tight
junctions
SipB (SspB) SPI-1 Shigella IpaB SPI-1 TTSS translocon component Cholesterol SPI-1 effector delivery, apoptosis of
phagocytes
SipC (SspC) SPI-1 Shigella IpaC SPI-1 TTSS translocon component,
actin nucleation & bundling
Actin SPI-1 effector delivery, induces membrane
ruffling
SipD (SspD) SPI-1 Shigella IpaD Regulates SPI-1 effector secretion
SopA Outside SPI-1 Putative EHEC effector
(Genbank NP_309587.1)
E3 ubiquitin ligase HsRMA1 Disrupts SCV integrity, induces PMN
transmigration
SopB (SigD) SPI-5 Shigella spp. IpgD, cellular
4-phosphatases,
synaptojanin
Inositol polyphosphate
phosphatase
Inositol phosphates Promotes membrane fission & macropinosome
formation, maintains perinuclear SCV
positioning, promotes epithelial cell survival,
triggers nitric oxide production in
macrophages, promotes fluid secretion,
disrupts tight junctions
SopE Bacteriophage
SopEf
Salmonella SopE2 Guanine exchange factor (GEF)
mimic
Rac-1, Cdc42 Induces membrane ruffling & proinflammatory
responses, promotes fusion of SCV with early
endosomes, disrupts tight junctions
SopE2 In vicinity of
bacteriophage
remnants
Salmonella SopE GEF mimic Cdc42 Induces membrane ruffling & proinflammatory
responses, increases macrophage iNos
expression, disrupts tight junctions
SptP SPI-1 N-terminus: Yersinia YopE,
Pseudomonas aeruginosa
ExoS. C-terminus: cellular
tyrosine phosphatases,
Yersinia YopH
GTPase activating protein (GAP)
mimic, tyrosine phosphatase
Cdc42, Rac-1, vimentin Returns host cytoskeleton to resting state
following bacterial entry, downregulates
proinflammatory responses
SlrPa Outside SPI-1/
SPI-2
Salmonella SspH1/H2,
GogB, Yersinia YopM,
Shigella IpaH7.8/9.8
Ubiquitin ligase? Confers host specificity?
SopDa Outside SPI-1/
SPI-2
Salmonella SopD2 Promotes membrane fission & macropinosome
formation, contributes to Salmonella virulence
and persistence in mice, induces fluid
secretion, promotes invasion of T84 cells
SspH1a Bacteriophage
Gifsy-3
Salmonella SspH2, SlrP,
GogB, Yersinia YopM,
Shigella IpaH7.8/9.8
E3 ubiquitin ligase PKN1 Downregulates proinflammatory responses
SteA
(STM1583)a
Outside SPI-2 Required for efficient mouse spleen
colonisation
SteB
(STM1629)a
Outside SPI-2 Putative picolinate reductase
a Can also be translocated via the SPI-2-encoded T3SS.
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Table 2
Effectors requiring the SPI-2-encoded T3SS for their translocation.
Effector Gene location Selected homologues Activity Host cell target(s) Role in infection
GogB Bacteriophage Gifsy-1 N-terminus: Yersinia YopM, Shigella
IpaH7.8/9.8, Salmonella SspH1/2, SlrP.
C-terminus: Yersinia YP2634/Y1471,
rabbit EPECOrfL, EHEC 0157:H7 Z1829
PipB SPI-5 Salmonella PipB2
PipB2 Outside SPI-2 Salmonella PipB Kinesin-1 Promotes Sif extension, recruits kinesin-1 to SCV
SifA Outside SPI-2 Salmonella SifB Rab mimic? SKIP, Rab7/9 Required for SCV membrane integrity & Sif formation,
maintains perinuclear SCV positioning, redirects exocytic
vesicles to SCV
SifB Outside SPI-2 Salmonella SifA
SopD2 Outside SPI-2 Salmonella SopD Contributes to Sif formation, required for efficient bacterial
replication in macrophages & mice
SpiC (SsaB) SPI-2 Hook 3, TassC Interferes with vesicular trafficking, role in SCV-associated
actin polymerisation (VAP) and Sif formation, controls
order of protein export through SPI-2 T3SS
SseF SPI-2 Contributes to Sif formation, recruits dynein to SCV,
maintains perinuclear SCV positioning, required for
formation of microtubule bundles around SCV, redirects
exocytic transport vesicles to SCV
SseG SPI-2 As SseF
SseI
(SrfH/GtgB)
Bacteriophage Gifsy-2 Filamin, TRIP6 Remodels SCV associated F-actin? Promotes phagocyte
motility
SseJ Outside SPI-2 Deacylase, phospholipase A
& glycerol-phospholipid
:cholesterol acyltransferase
Cholesterol Negative regulation of Sifs, antagonises SifA SCV
stabilisation
SseK1 Outside SPI-2 Salmonella SseK2/3, Citrobacter
rodentium NleB, EHEC Z4328
SseK2 Outside SPI-2 Salmonella SseK1/3, Citrobacter
rodentium NleB, EHEC Z4328
SseK3 (NleB)a ST64B coliform
bacteriophage
Salmonella SseK1/2, Citrobacter
rodentium NleB, EHEC Z4328
SseL Outside SPI-2 Cysteine protease with
deubiquitinase activity
IkBa Macrophage apoptosis, downregulates inflammatory
responses
SspH2 In vicinity of
bacteriophage
remnants
Salmonella SspH1, SlrP, GogB, Yersinia
YopM, Shigella IpaH7.8/9.8
Inhibits actin polymerisation
in vitro
Filamin, Profilin Remodels SCV associated F actin?
SteC
(STM1698)
Outside SPI-2 Eukaryotic kinases Serine/Threonine kinase Required for VAP
SpvBb pSLT (S. typhimurium) N-terminus: Photorhabdus luminescens
TcaC. N-terminus: Bacillus cereus
VipB2, Clostridium botulinum C2 toxin
component 1/C3 toxin, Clostridium
perfringens Iota
ADP ribosyl transferase,
inhibits actin polymerisation
in vitro, depolymerises
F-actin upon transfection
Actin Inhibition of VAP, apoptosis of infected cells, required for
full virulence in mice
SpvCb pSLT (S. typhimurium) Shigella OspF, Pseudomonas syringae
HopAI1
Phosphothreonine lyase Required for full virulence in mice
a Found in S. typhimurium SL1344, not LT2.
b Found in non-typhoid Salmonella serovars.
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Salmonella takes control: effector-driven manipulation of the host McGhie et al. 121SopB-dependent hydrolysis of PI(4,5)P2 at the ruffling
host membrane enhances the subsequent annealing of
plasmalemmal invaginations to rapidly enclose bacteria
within a sealed phagosome (the SCV) [6]. In addition,
SopB-dependent formation of PI(3)P at the host plasma
membrane has been reported to contribute towards the
formation of larger, more stable macropinosomes [6] and
has been shown to facilitate bacterial phagocytosis by
recruiting the host SNARE protein VAMP8 [9]. Another
effector, SopD, cooperates with SopB to aid membrane
fission and macropinosome formation [10].
Following engulfment Salmonellae return the host cell
cytoskeleton back to its resting state, an event mediated
by the N-terminal GTPase activation (GAP) domain of
SptP. This stimulates the intrinsic GTPase activities of
SopE/SopE2/SopB-activated Cdc42 and Rac-1, causing
their downregulation [6].
Maturation and trafficking of the Salmonella-
containing vacuole
When SCVs form, they acquire transiently cellular mar-
kers associated with the early endocytic pathway, e.g. the
transferrin receptor (TfnR), early endosomal antigen 1
(EEA1) and several RabGTPases such as Rab4, Rab5 and
Rab11, and SCVs mature in a Rab7-dependent manner
[11]. SCVs may then uncouple from the endocytic path-
way, to avoid lysosomal fusion [11], although recent
evidence suggests that late endosome/lysosome (LE/
Lys) content is continually delivered to the SCV in a
Rab7- andmicrotubule-dependent manner [12]. Regard-
less of whether this LE/Lys interaction occurs, as the SCV
matures, early markers are sequentially replaced by late
endosome/lysosome markers including Rab7, vacuolar
ATPase (v-ATPase) and lysosomal membrane glyco-
proteins (lpgs) e.g. LAMP-1 [11].
SopE and the inositol phosphatase activity of SopB are
required for SCV recruitment of Rab5 [13,14], which
binds the phosphatidylinositol 3-kinase Vps34 required
for LAMP-1 recruitment [11,14]. Vps34 in turn gener-
ates PI(3)P on the SCV membrane [14], which is
necessary for the recruitment of EEA1 [11]. SopB also
inhibits the degradation of epidermal growth factor recep-
tors (EGFR) by lysosomes [15], and has been recently
shown to recruit sorting nexin-1 (SNX-1), which likely
contributes to the disappearance of late endosomal/lyso-
somal markers, such as the mannose 6-phosphate recep-
tor, from the maturing SCV [16]. These observations in
combination suggest that SopB plays a key role in divert-
ing SCV trafficking from the endosomal maturation path-
way. SopB is additionally required for activation of Akt
[4], which in turn deactivates the Rab14 GAP, AS160.
Activated Rab14 increases intracellular Salmonella repli-
cation, possibly by delaying SCV-lysosomal fusion [17].
In addition, SpiC is thought to prevent fusion of macro-
phage late endosomes/lysosomes with the SCV [11].www.sciencedirect.comThe SPI-2 effector SseJ is required for full virulence
during systemic infection of mice and localises to SCVs
[18]. It has deacylase activity in vitro [19] and during
Salmonella infection it esterifies cholesterol, a lipid
enriched in SCV membranes. SseJ also exhibits phospho-
lipase A activity [20].
The SPI-1 effector SopA structurally and functionally
mimics cellular HECT E3 ubiquitin ligases [21], pro-
moting bacterial escape from the SCV in HeLa cells. It
may, therefore, have a role in disrupting SCV integrity
[11] although the significance of this activity is unclear.
Several hours post-infection of host cells, an F-actin
meshwork assembles around the replicative SCV
[11,22], which appears to be bound and stabilised by
SipA [23]. Several SPI-2 effectors may also regulate
SCV-associated actin dynamics. In particular, the kinase
SteC is essential for the formation of SCV-associated F-
actin [22], while SseI and SspH2 co-localise with SCV-
associated F-actin and bind the host actin-crosslinking
protein filamin [24]. Furthermore, SspH2 interacts with
the cellular G-actin binding protein profilin and inhibits
actin polymerisation rates in vitro [24]. The plasmid-
encoded effector SpvB ADP ribosylates monomeric actin
preventing its polymerisation and inhibits the formation
of SCV-associated F-actin [24].
SCV positioning and formation of Salmonella-
induced filaments (Sifs)
As it matures, the SCV migrates towards the perinuclear
region of the host cell by transiently recruiting the Rab7-
interacting lysosomal protein (RILP), which in turn
associates with the minus end-directed microtubule
motor, dynein [25]. Maintaining the SCV within the
perinuclear region appears to be important for promoting
bacterial replication. The close proximity of the SCV to
the Golgi may facilitate interception of endocytic and
exocytic transport vesicles to obtain nutrients and/or
membrane [25]. In support of this, SifA, SseG and SseF
are required for re-direction of exocytic transport vesicles
to the SCV [26].
SseG and SseF have been suggested tomaintain the SCV
in the perinuclear region by forming a functional com-
plex [27] that either ‘tethers’ the SCV to the Golgi
apparatus or manipulates dynein activity [25]. By con-
trast, SifA binds the host protein SKIP (SifA and kinesin
interacting protein) to downregulate PipB2-induced
recruitment of the plus end-directed microtubule motor
kinesin to the SCV [28,29]. Efficient localisation of
SifA to the SCV is mediated by the SPI-1 effector SipA
[23]. SopB-mediated phosphorylation of the actin-associ-
ated motor myosin II light chain (MLC), most likely via
the Rho/ROCK/MLC signalling pathway, is also
required for retention of the SCV within the perinuclear
region of the host cell [30].Current Opinion in Microbiology 2009, 12:117–124
122 Hosticrobe interactions: BacteriaOnce the SCV is positioned, the bacteria begin to repli-
cate. This replicative stage is characterised by the for-
mation of LAMP-rich specialised tubulovesicular
structures termed Salmonella-induced filaments (Sifs) that
extend away from the SCV along the microtubule net-
work. Sifs are thought to be generated by fusion of late
endosomes/lysosomes with the SCV [11], although their
precise role in infection is undetermined. SifA is essential
for Sif formation [11] and maintenance of SCV integrity
[18]. Its transient overexpression is sufficient to induce
swelling and aggregation of late endosomes and formation
of Sif-like tubules in mammalian cells [11]. Although the
molecular mechanism by which SifA induces Sif for-
mation is unclear, the effector has been shown to interact
with Rab7 and is suggested to promote Sif extension by
uncoupling Rab7 from RILP, preventing the recruitment
of dynein to Sifs [25]. The SPI-2 effector PipB2 also
promotes Sif extension, most probably through a direct
interaction with kinesin-1 [28,31].
Both SseF and SseG are thought to augment Sif formation
by modulating the aggregation of endosomal compart-
ments. Salmonella mutants lacking sseF, sseG or another
SPI-2 effector gene, sopD2 induce fewer Sifs compared
with wild type bacteria, but form a greater number of
filamentous aggregates with punctate LAMP-1 distri-
bution within infected cells. These ‘pseudo-Sifs’ may
represent Sif precursors [25,32].
By contrast, both SseJ and SpvB antagonise Sif formation.
Mutation of sseJ or spvB increases the number of Sifs [25],
and transfection of epithelial cells with SseJ before Sal-
monella infection inhibits Sif formation [18]. SseJ activity
also appears to be required for loss of SCV integrity as, in
contrast to a sifAmutant, a sifA sseJ double mutant retains
its vacuolar membrane [18].
Modulation of the innate immune response
and host cell death
SPI-1 effectors additionally induce acute intestinal inflam-
mation, a hallmark of Salmonella infection. Stimulation of
Cdc42 by SopE/SopE2/SopB during Salmonella invasion
leads to Raf1-dependent upregulation of Erk, Jnk and p38
mitogen-activated protein kinase (MAPK) pathways and
subsequent activation of the transcription factors AP-1 and
NFkB [4,6,8]. This results in the release of proinflamma-
tory cytokines including IL-8, stimulating the recruitment
of polymorphonuclear leukocytes (PMNs). Simul-
taneously, a SipA N-terminal region triggers a novel
Arf6- and phospholipaseD signalling cascade that activates
protein kinase Ca, leading to apical secretion of the potent
PMN chemoattractant hepoxillin A3 [4,33]. This promotes
PMN transmigration across the epithelium into the intes-
tinal lumen [4,33], which is probably augmented by the E3
ubiquitin ligase activity of SopA [21]. PMNtransmigration
appears to contribute towardsdiarrhoealdisease, enhancing
Salmonella transmission via the faecal-oral route.Current Opinion in Microbiology 2009, 12:117–124Ins(1,4,5,6)P4 production via SopB inositol phosphatase
activity also plays a role in the induction of diarrhoea by
promotingcellular chloride ion secretionandfluidflux [4,6],
while SopD contributes towards enteritis in infected calves
through an unknown mechanism [4]. Disruption of intes-
tinal epithelial cell tight junctions by SopB, SopE, SopE2
and SipA is also likely to promote fluid flux and PMN
transmigration [34], although intriguingly, another SPI-1
effector, AvrA has been recently shown to counteract this
activity [35].
Inflammatory responses are further augmented by effec-
tor-induced macrophage cell death. This was thought to
be due to direct activation of caspase-1 by SipB, resulting
in release of proinflammatory cytokines [4], but has been
shown to depend on the delivery of flagellin into the
macrophage cytosol, possibly via the SPI-1 T3SS [36].
SipB additionally triggers a delayed caspase-1-indepen-
dent cell death [4,36]. More recently, SpvB and SseL
have been reported to induce a slower SPI-2-dependent
cell death pathway [37,38].
Salmonella also deliver effectors that suppress cellular
immune responses. Both SptP GAP and tyrosine phos-
phatase activities play a role in reversing MAPK acti-
vation [39,40] and AvrA acetyltransferase activity towards
specific mitogen-activated protein kinase kinases
(MAPKKs) prevents Jnk activation [41]. SpvC also
directly inhibits Erk, Jnk and p38 MAPKs through its
phosphothreonine lyase activity [42,43].
Finally, Salmonella targets transcription factors down-
stream of MAPK pathways. The SPI-2 deubiquitinase
SseL suppresses NFkB activation by impairing IkBa
ubiquitination and degradation [44], an activity also
reported for AvrA [45]. SspH1 additionally inhibits
NFkB-dependent gene expression, possibly via ubiqui-
tination of the host cell kinase PKN1 [46].
Perspectives–effector localisation and
cooperation
Salmonellae have evolved an array of subversive SPI-1 and
SPI-2 effector proteins with diverse biochemical activities.
The actions of individual SPI-1 effectors during Salmonella
entryhavebeen intensively studied,but it isnot clearwhich
effectors are present in the host cell at any one time, nor are
the sequence and kinetics of effector translocation estab-
lished, although work has begun to dissect this complex
process [47]. Likewise, it is still not completely understood
how the discrete activities of all of these effectors are
controlled, though effectors do appear to have varied
half-lives following their translocation [6]. Work on the
localisation of effectors has shown that in addition to the
translocase SipB, six other SPI-1 effectors (SipA, SipC,
SopB, SopE, SopE2 and SptP) are delivered to the host
plasma membrane, suggesting that this may provide an
interface for effector–effector interplay [48] as well aswww.sciencedirect.com
Salmonella takes control: effector-driven manipulation of the host McGhie et al. 123effector-target interaction(s) [49] during bacterial entry.
Combinatorial screens [50] have confirmed known/pro-
posed effector interactions [3,48], and suggested two novel
cooperative associations, SipC–SopB and SipC–SopE [50],
which require further investigation. However, interactions
of SPI-2 effectors with their host cell targets, as well as with
each other is a less well-understood area of Salmonella
pathogenesis.
Recent work has challenged the conventional view that
SPI-1 effectors solelymediateSalmonella invasion and SCV
biogenesis, while SPI-2 effectors promote intracellular bac-
terial replication and systemic spread. SipA [23], SopB [30]
and SptP (Humphreys et al., unpublished) all persist in host
cellshoursafterbacterial invasionandhavekeyroles inSCV
positioning and/or intracellular replication (Figure 1),
suggesting possible interplay between SPI-1 and SPI-2
effectors. Indeed,SipAhasalreadybeenshowntocooperate
with SifA to mediate perinuclear SCV positioning [23].
Continued studies of effector action and interplay seem
likely to explain further the processes underlying infection
and highlight new facets of eukaryotic cell biology.
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